Clinical Trial Update: Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating zoledronate to prevent osteoporosis in patients with primary malignant glioma; the study has completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma
• Osteoporosis

Drugs mentioned

• Zoledronate (zoledronic acid)

Snippet

Sponsor: Duke University | Conditions: Brain Tumors, Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2013-01-16